Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Revenue (2020 - 2025)

Historic Revenue for Relay Therapeutics (RLAY) over the last 6 years, with Q2 2025 value amounting to $677000.0.

  • Relay Therapeutics' Revenue changed N/A to $677000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year decrease of 1649.01%. This contributed to the annual value of $10.0 million for FY2024, which is 6082.75% down from last year.
  • Per Relay Therapeutics' latest filing, its Revenue stood at $677000.0 for Q2 2025.
  • Over the past 5 years, Relay Therapeutics' Revenue peaked at $25.2 million during Q3 2023, and registered a low of -$1000.0 during Q4 2023.
  • Over the past 5 years, Relay Therapeutics' median Revenue value was $567000.0 (recorded in 2021), while the average stood at $3.2 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 2823333.33% in 2021, then tumbled by 10039.53% in 2023.
  • Relay Therapeutics' Revenue (Quarter) stood at $567000.0 in 2021, then crashed by 55.38% to $253000.0 in 2022, then plummeted by 100.4% to -$1000.0 in 2023, then soared by 1000800.0% to $10.0 million in 2024, then plummeted by 93.23% to $677000.0 in 2025.
  • Its Revenue was $677000.0 in Q2 2025, compared to $7.7 million in Q1 2025 and $10.0 million in Q1 2024.